Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
Study Details
Study Description
Brief Summary
The purpose of this study is to determine if new MRI methods that measure various information and chemical makeup in the brain, will give early information regarding response to treatment in patients with brain tumors.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The purpose of this study is to see if new MRI methods which measure information related to water, blood flow, and chemical makeup in the brain, can give early information of how well treatment is working in patients with brain tumors.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| A Evaluation of new MRI methods that measure information related to the chemical makeup of the brain in patients undergoing therapy for brain tumors. |
Procedure: MRI
New MRI methods which measure information related to water, blood, and chemical makeup in the brain.
|
Outcome Measures
Primary Outcome Measures
- MRI metrics for brain tumor response [approximately 1 year]
New treatment response MRI metrics derived from change in water diffusion and perfusion from pre-treatment to mid-treatment will be compared to traditional response metrics measured 4 weeks after completion of standard of care chemoradiation for their prediction of patient outcomes and overall survival. The new response metrics are not only measured earlier, but are also quantitative measures for the fraction of tumor exhibiting significant change in diffusion and perfusion assessed on a voxel-by-voxel basis, as well as the volume of dense tumor assessed by analysis of diffusion/perfusion histograms measured over the whole tumor.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients over the age of 18 who have been diagnosed with a brain tumor of the central nervous system and a treatment plan has been discussed.
-
Must be willing/able to undergo 3-5 MRI scans with IV contrast.
-
You can take part in this study if you are NOT afraid of small, enclosed places.
Exclusion Criteria:
-
A patient who is claustrophobic.
-
Females who are pregnant or lactating.
-
Patients who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prosthesis or or implanted neurological stimulator.
-
Any patient who has a history of allergic reactions to MR contrast agent (Omniscan, Magnevist, MultiHance)
-
Patients who require general anesthesia to complete MRI exam or patients who have had a negative reaction to MRI sedation. (Chloral Hydrate, Pentobarbital or Versed)
-
You should NOT have any metals, or implanted devices in your body (such as aneurysm clips, pacemakers, or artificial joints or limbs.). You will need to tell us about your medical history including any surgeries you have had.
Also, if your job or any other experience might have left metal fragments in your body, please let us know, as the MRI has a strong magnetic field could move a metal fragment in your body or interfere with an implanted device, such as a pacemaker, causing you harm.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Univeristy of Michigan Health System | Ann Arbor | Michigan | United States | 48109 |
Sponsors and Collaborators
- University of Michigan
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Thomas L. Chenevert, Ph.D, University of Michigan
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HUM 00051052
- 5P01CA085878-12
- CA85878-12